CORESTEMCHEMON Inc. (KOSDAQ:166480)
South Korea · Delayed Price · Currency is KRW 2,915.00
-255.00 (-8.04%)
At close: Jun 5, 2026
CORESTEMCHEMON Market Cap
CORESTEMCHEMON has a market cap or net worth of 129.31 billion as of June 5, 2026. Its market cap has increased by 57.75% in one year.
Market Cap
129.31B
Enterprise Value
163.88B
Revenue
18.39B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,915.00
Market Cap Chart
Since June 26, 2015, CORESTEMCHEMON's market cap has decreased from 653.85B to 129.31B, a decrease of -80.22%. That is a compound annual growth rate of -13.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 129.31B | 57.74% |
| Dec 30, 2025 | 81.98B | -13.27% |
| Dec 30, 2024 | 94.52B | -34.79% |
| Dec 28, 2023 | 144.95B | -43.25% |
| Dec 29, 2022 | 255.40B | -13.00% |
| Dec 30, 2021 | 293.58B | -19.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ViGenCell | 194.74B |
| TiumBio | 186.54B |
| Bio Solution | 180.37B |
| Ensol Biosciences | 172.98B |
| ABION | 158.85B |
| Prestige Biologics | 142.13B |
| ISU Abxis | 132.93B |
| Cell Biotech | 111.76B |